FDA Approved: AZACITIDINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for azacitidine from Accord Healthcare Inc., enabling continued regulatory authorization of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

SUPPL AP for AZACITIDINE (AZACITIDINE)